Login    Join free Add to favorites    中文
home > news > International Phenome Centre Network Launches with Waters as a Founding Partner
Industry Updates | New Products | Supplier News | Upcoming Events | business | web
International Phenome Centre Network Launches with Waters as a Founding Partner

hits:185     Date:12/01/16
Global consortium will advance precision medicine research through metabolic phenotyping
 
MILFORD, Mass.--(BUSINESS WIRE)--A consortium of leading research centers from six different countries today launched theInternational Phenome Centre Network (IPCN) at the 2016 World Innovation Summit for Health (WISH) in Doha, Qatar. Through its commitment to harmonized metabolic phenotyping methods, the IPCN will tackle some of the most pressing global health challenges, such as autism, cancer, diabetes, dementia and obesity. Supporting the network with its chromatography and mass spectrometry technologies and expertise, Waters Corporation (NYSE:WAT) is a founding corporate partner of the IPCN.
 
An advance in precision medicine research, metabolic phenotyping examines the dynamic interactions between our genes, environments, microbiomes, diets and lifestyles and their impact on disease. The research is made possible through advanced analytical science, including mass spectrometry.
 
Waters is a world leader in mass spectrometry technologies and methods. It collaborates with IPCN institutions around the world to apply cutting-edge analytical and mathematical approaches to study robust and harmonized data representing the world鈥檚 diverse populations. The results could unravel the molecular underpinnings of disease and inform the development of new therapies and global public health policies.
 
鈥淲e are excited by the revolutionary potential of the International Phenome Centre Network to harmonize the way researchers around the world collect and assess data through metabolic phenotyping,鈥 said Rohit Khanna, Senior Vice President, Applied Technology, at Waters Corporation. 鈥淚t has been a privilege working with world-class institutions to develop and use technologies that will drive solutions to our most complex global health care challenges.鈥
 
Initiated by the MRC-NIHR National Phenome Centre (NPC) at Imperial College London, the IPCN includes more than a dozen international partners with regional, multi-institutional hubs in Australia, Canada, China, Japan, Singapore, Taiwan, the United States and the United Kingdom.
 
Waters has long supported collaboration and the harmonization of research techniques and standards across geographies and through partnerships with industry, governments, academic centers and health systems. It has provided funding support for metabolic profiling training centers, including the Imperial International Phenome Training Centre.
 
鈥淲e are grateful for Waters鈥 collaboration in the creation of internationally harmonized centers of analytical science, focused on understanding gene-environment interactions that underpin disease risk, the comparative biology of major diseases and addressing unmet healthcare and medical needs,鈥 said Jeremy Nicholson, Director of the NPC and Head of Department of Surgery and Cancer at Imperial College London. 鈥淲aters鈥 expertise and international leadership in mass spectrometry and analytical science has been instrumental to the network鈥檚 success.鈥
 
About Waters Corporation (www.waters.com)
Waters Corporation (NYSE:WAT) develops and manufactures advanced analytical and material science technologies for laboratory dependent organizations. For more than 50 years, the company has pioneered a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis systems.
Related News>> more
advertisement

Copyright(C) 2006-2017 Bio-Equip    E-mail:web@bio-equip.cn   娌狪CP澶06040519鍙